Amtech Systems (ASYS)
(Delayed Data from NSDQ)
$6.36 USD
+0.10 (1.60%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $6.36 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.36 USD
+0.10 (1.60%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $6.36 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Zacks News
Amtech Systems (ASYS) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Amtech (ASYS) delivered earnings and revenue surprises of 75% and 2.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Amtech Systems (ASYS) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Amtech (ASYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Texas Instruments (TXN) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Texas Instruments (TXN) delivered earnings and revenue surprises of 8.29% and 4.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Amtech Systems (ASYS) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Amtech (ASYS) delivered earnings and revenue surprises of 40% and 24.22%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Amtech Systems (ASYS) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
Amtech (ASYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Intel (INTC) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Intel (INTC) delivered earnings and revenue surprises of 21.11% and 6.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for January 17th
by Zacks Equity Research
ASYS, APPN, and BALY have been added to the Zacks Rank #5 (Strong Sell) List on January 17, 2022
Amtech Systems (ASYS) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Amtech (ASYS) delivered earnings and revenue surprises of 200.00% and 7.44%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Amtech Systems (ASYS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Amtech (ASYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amtech Systems (ASYS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Amtech (ASYS) delivered earnings and revenue surprises of -166.67% and 9.94%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Amtech Systems (ASYS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Amtech (ASYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Avid Bioservices, Oncternal Therapeutics, Amtech Systems and Aytu Biopharma
by Zacks Equity Research
Zacks.com featured highlights include: Avid Bioservices, Oncternal Therapeutics, Amtech Systems and Aytu Biopharma
5 Stocks to Buy on New Analyst Coverage
by Shrabana Mukherjee
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Interactive Brokers (IBKR), Avid (CDMO), Oncternal (ONCT), Amtech (ASYS) and Aytu.
Zacks.com featured highlights include: Amtech Systems, Howard Bancorp, Kingstone Companies and Grafton Group
by Zacks Equity Research
Zacks.com featured highlights include: Amtech Systems, Howard Bancorp, Kingstone Companies and Grafton Group
4 Affordable Breakout Stocks for Stunning Returns
by Nitish Marwah
The first step to selecting the right breakout stocks is to calculate their support and resistance levels.
These 5 Stocks Are Safe Bets Courtesy of New Analyst Coverage
by Shrabana Mukherjee
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like UFP Industries (UFPI), Interactive Brokers (IBKR), Avid (CDMO), Amtech (ASYS) and GAIA
Why Amtech Systems (ASYS) Stock Might be a Great Pick
by Zacks Equity Research
Amtech Systems (ASYS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Strength Seen in Amtech (ASYS): Can Its 5.9% Jump Turn into More Strength?
by Zacks Equity Research
Amtech (ASYS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Amtech Systems (ASYS) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Amtech (ASYS) delivered earnings and revenue surprises of 155.56% and 8.94%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Amtech Systems (ASYS) Q3 Earnings Expected to Decline
by Zacks Equity Research
Amtech (ASYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amtech (ASYS) Upgraded to Buy: Here's Why
by Zacks Equity Research
Amtech (ASYS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Earnings Preview: Amtech Systems (ASYS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Amtech (ASYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amtech Systems (ASYS) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Amtech (ASYS) delivered earnings and revenue surprises of 140.00% and 29.33%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Amtech Systems (ASYS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Amtech (ASYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amtech Systems Enters Overbought Territory: Is A Drop Coming?
by Zacks Equity Research
Amtech Systems has moved higher as of late, but there could definitely be trouble on the horizon for this company